Dampskibsselskabet Norden AS (0HDP)
London Exchange · UK · prices in DKK · close of 23 Oct 2026
Key indicators
| Last close | DKK 361.40 |
|---|---|
| 52-week range | 237.40 – 404.80 |
| Return, 1 month / 3 months | −4.6% / +8.8% |
| Return, 1 year / 3 years | +46.1% / +0.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 38 |
| Volatility (1 year) | 38.9% |
| Worst drawdown (1 year) | -16.7% |
| Average daily value traded | 0.57M DKK |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dampskibsselskabet Norden is a Danish shipping company based in Copenhagen that operates dry cargo vessels and tankers. Its dry cargo fleet carries bulk commodities such as grain, coal, iron ore and other raw materials for industrial customers and trading houses, while its tanker business transports refined oil products. The company serves commodity producers, traders and energy companies, chartering its ships on short and long voyages across global sea routes.
Dampskibsselskabet Norden AS trades under the code 0HDP on the London Exchange in UK, with its price quoted in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dampskibsselskabet Norden AS (0HDP) trades on the London Exchange in UK. It last closed at DKK 361.40 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 749 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 46.1% and over the last three months it rose 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.8% | ||
| From 52-week high | -10.2% | ||
| Momentum | 84 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.8% | ||
| 6-month return | 26.2% | ||
| 12-month return, skipping the last month | 53.1% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.7% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.57M DKK | ||
| Zero-volume days | 10.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | −4.6% |
| 3 months | +8.8% |
| 6 months | +26.2% |
| 1 year | +46.1% |
| 3 years | +0.8% |
| 5 years | +266.4% |
Signals
| 50-day / 200-day average | 377.32 / 317.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 14.60 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | DKK 2.0000 |
| 12 Mar 2026 | DKK 2.0000 |
| 31 Oct 2025 | DKK 2.0000 |
| 15 Aug 2025 | DKK 2.0000 |
| 2 May 2025 | DKK 2.0000 |
| 13 Mar 2025 | DKK 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.